Status:

WITHDRAWN

Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion

Lead Sponsor:

Seoul National University Hospital

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of this study is to compare the efficacy of transarterial chemoembolization with adriamycin to transarterial chemoembolization with adriamycin/transarterial chemoinfusion with cisplatin combin...

Detailed Description

Potentially curative treatments for hepatocellular carcinoma (HCC) include surgical resection, liver transplantation, and local ablative therapy. However, HCC patients are diagnosed at advanced stage...

Eligibility Criteria

Inclusion

  • Patients with clinical or histological diagnosis of HCC based on the guidelines of the AJCC
  • Patients with advanced HCC with invasion of major branch(es) of portal vein in the arterial phase of dynamic CT or MRI
  • Patients who have received previous local therapy treatments (RFA, PEI, cryoablation, surgery, resection) are eligible
  • Age : 18 years to 80 years
  • ECOG Performance Status of 0 to 2
  • Child-Pugh class A (Child-Pugh score 5-6)
  • Adequate bone marrow, liver function as assessed by the following laboratory requirements to be conducted within 7 days prior to screening:
  • WBC count \> 2,000/mm3
  • Absolute neutrophil count \> 1,000/mm3
  • Hb ≧ 8.0 g/dL
  • Platelet count ≧ 50,000 /mm3
  • Bilirubin ≦ 3 mg/dL
  • Adequate clotting function: INR \< 2.3 or \< 6sec

Exclusion

  • Child-Pugh score ≧ 7
  • ECOG Performance Status ≧ 3
  • Patients with chronic kidney disease or serum creatinine ≥ 1.2 mg/dL
  • History of organ allograft
  • Patients with uncontrolled co-morbidity which needs treatment
  • Patients who have received prior systemic chemotherapy
  • Patients with extrahepatic metastasis

Key Trial Info

Start Date :

July 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01857726

Start Date

July 1 2013

End Date

December 1 2016

Last Update

April 28 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University Hospital

Seoul, South Korea